⁶⁸Ga-NOTA-Functionalized Ubiquicidin: Cytotoxicity, Biodistribution, Radiation Dosimetry, and First-in-Human PET/CT Imaging of Infections.

Abstract

Ubiquicidin is an antimicrobial peptide with great potential for nuclear imaging of infectious diseases, as its cationic-rich fragment TGRAKRRMQYNRR (UBI) has been functionalized with NOTA to allow complexation to ⁶⁸Ga (⁶⁸Ga-NOTA-UBI). We herein assess the cytotoxicity and radiation dosimetry for ⁶⁸Ga-NOTA-UBI and a first-in-human evaluation to diagnose infectious processes. <b>Methods:</b> Cytotoxicity was evaluated in green monkey kidney epithelial (Vero) cells and MT-4 leukocytes. Tracer susceptibility was studied in vitro using different bacterial and fungal strains. PET/CT-based biodistribution, pharmacokinetics, and radiation dosimetry were performed on nonhuman primates. Two healthy volunteers and 3 patients with suspected infection underwent ⁶⁸Ga-NOTA-UBI PET/CT imaging. <b>Results:</b> Negligible cytotoxicity was determined for NOTA-UBI. ⁶⁸Ga-NOTA-UBI showed moderate blood clearance (29-min half-life) and predominant renal clearance in nonhuman primates. Human radiation dose estimates indicated the bladder wall as the dose-critical tissue (185 μSv/MBq), followed by the kidneys (23 μSv/MBq). The total absorbed body dose was low (<7 μSv/MBq); the effective dose was estimated at 17 μSv/MBq. ⁶⁸Ga-NOTA-UBI could diagnose bone- and soft-tissue infection in 3 of 3 patients. <b>Conclusion:</b>⁶⁸Ga-NOTA-UBI is considered a nontoxic, safe-to-administer radiopharmaceutical unlikely to cause adverse effects in humans. The favorable tracer biodistribution and the first-in-human results will make ⁶⁸Ga-NOTA-UBI PET/CT an encouraging future diagnostic technique with auxiliary clinical relevance.